HealthStream, Inc. (HSTM) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
HealthStream, Inc. · Health Care · ref. ETF XLV · 40 calls · price $28.83
What the company does: HealthStream, Inc. provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States.
📈 HealthStream, Inc. (HSTM) stock price
$28.83+2.7% over range
Aug 28, 25low $19.88 · high $29.8Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
0% recommend buying · 1 analysts
📊 JPI status : HealthStream, Inc. has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
⚠️ The stock trades above the median target: it has beaten expectations. The “Hold” reflects conviction on the company, but the remaining quantified upside is low/negative.
🎯 HSTM price target & analyst consensus — price $28.83
The price target · all analysts combined (1 targets)
Highest target · 1 firm of 1$27-6.3%
Median target · of 1 targets$27-6.3%
Lowest target · 1 firm of 1$27-6.3%
Current price$28.83
⭐ What the most reliable analysts say
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
The consensus · 1 ratings (last 6 months)
Strong Buy00%
Buy00%
Hold1100%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 HSTM price target all
All 40 calls, one by one, with our verdict on each firm.
→ See all 40 targets, analyst by analyst💡 The best analysts on HSTM most reliable
Their real reliability on HSTM, firm by firm: who was right, who was wrong.
→ See their reliability on HSTMAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about HealthStream, Inc.? The JPI assistant answers using our backtest data.
🔎 Detailed analyses
✅ Historical analyst reliability on HSTM
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Baird ↗ | 50% | +4.8% | 2 |
| First Analysis | 50% | -3.0% | 2 |
| Needham ↗ | 50% | -6.7% | 2 |
| Northland Capital Markets ↗ | 50% | -11.4% | 2 |
📊 What $1,000 invested in HealthStream, Inc. would be worth › open the full page
In short — $1,000 invested in HealthStream, Inc. 10 years ago would be worth $1,292 today, i.e. +3%/yr on average. Best year: 2021 (+21%), worst: 2025 (-27%). Price performance, excluding dividends.
If I'd invested $1,000 in HealthStream, Inc.
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $894 | -11% |
| 3 years ago | $1,144 | +14% |
| 5 years ago | $1,301 | +30% |
Return by year (HealthStream, Inc.)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +23% | $1,232 (+23%) |
| 2025 | -27% | $894 (-11%) |
| 2024 | +18% | $1,051 (+5%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on HealthStream, Inc.
Loading news…
📋 All analyst calls on HSTM
Filtered on — · ✕ show all
Canaccord Genuity ↗
Jul 21, 26
■ Hold neutral · not a buy · 🎯$27
Price at call : $27.84 — gap to target -3%
Today : $28.83 — gap to target -6%
🎯 on HSTM : 0% (1 call matured) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Jul 21, 27
matures : Jul 21, 27
Canaccord Genuity ↗
May 7, 26
■ Hold neutral · not a buy · 🎯$24
Price at call : $23.54 — gap to target +2%
Today : $28.83 — gap to target -17%
🎯 on HSTM : 0% (1 call matured) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
Canaccord Genuity ↗
Dec 17, 25
■ Hold neutral · not a buy · 🎯$28
Price at call : $24.29 — gap to target +15%
Today : $28.83 — gap to target -3%
🎯 on HSTM : 0% (1 call matured) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Dec 17, 26
matures : Dec 17, 26
Canaccord Genuity ↗
Aug 8, 25
■ Hold neutral · not a buy · 🎯$28
Price at call : $25.98 — gap to target +8%
Today : $28.83 — gap to target -3%
🎯 on HSTM : 0% (1 call matured) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Aug 8, 26
matures : Aug 8, 26
Canaccord Genuity ↗
May 15, 25
■ Hold neutral · not a buy · 🎯$29
Price at call : $27.57 — gap to target +5%
Today : $28.83 — gap to target +1%
🎯 on HSTM : 0% (1 call matured) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : May 15, 26
matures : May 15, 26
Canaccord Genuity ↗
Feb 26, 25
■ Hold neutral · not a buy · 🎯$30
Price at call : $33.27 — gap to target -10%
Today : $28.83 — gap to target +4%
🎯 on HSTM : 0% (1 call matured) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Feb 26, 26
matures : Feb 26, 26
JMP Securities
Feb 6, 25
■ Market Perform neutral · not a buy
🎯 on HSTM : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Feb 6, 26
matures : Feb 6, 26
▲ Overweight · 🎯$34
Price at call : $28.63 — upside +19%
Today : $28.83 — upside +18%
Expected +19% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on HSTM : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
-7.4%
stock -7% · XLV -3%
matured Oct 23, 25
See the other 32 calls, newest to oldest
Canaccord Genuity ↗
Oct 23, 24
■ Hold neutral · not a buy · 🎯$29
Price at call : $28.63 — gap to target +1%
Today : $28.83 — gap to target +1%
🎯 on HSTM : 0% (1 call matured) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Oct 23, 25
matures : Oct 23, 25
Canaccord Genuity ↗
Jul 24, 24
■ Hold neutral · not a buy · 🎯$28
Price at call : $29.14 — gap to target -4%
Today : $28.83 — gap to target -3%
🎯 on HSTM : 0% (1 call matured) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Jul 24, 25
matures : Jul 24, 25
JMP Securities
Dec 6, 23
■ Market Perform neutral · not a buy
🎯 on HSTM : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Dec 5, 24
matures : Dec 5, 24
Canaccord Genuity ↗
Feb 22, 23
■ Hold neutral · not a buy · 🎯$26
Price at call : $25.72 — gap to target +1%
Today : $28.83 — gap to target -10%
🎯 on HSTM : 0% (1 call matured) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Feb 22, 24
matures : Feb 22, 24
Canaccord Genuity ↗
Apr 28, 21
■ Hold neutral · not a buy · 🎯$24
Price at call : $24.71 — gap to target -3%
Today : $28.83 — gap to target -17%
🎯 on HSTM : 0% (1 call matured) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Apr 28, 22
matures : Apr 28, 22
Canaccord Genuity ↗
Oct 28, 20
■ Hold neutral · not a buy · 🎯$20
Price at call : $18.34 — gap to target +9%
Today : $28.83 — gap to target -31%
🎯 on HSTM : 0% (1 call matured) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Oct 28, 21
matures : Oct 28, 21
Raymond James ↗
Dec 20, 19
■ Market Perform neutral · not a buy
🎯 on HSTM : no call matured yet · 📊 on Health : 39.9% · -2.0% (218 calls)
in progress (365j)
matures : Dec 19, 20
matures : Dec 19, 20
Barrington Research ↗
Jul 11, 18
■ Market Perform neutral · not a buy
🎯 on HSTM : 0% (1 call matured) · 📊 on Health : 35.1% · -4.0% (57 calls)
in progress (365j)
matures : Jul 11, 19
matures : Jul 11, 19
■ Neutral neutral · not a buy
🎯 on HSTM : 50% (2 calls matureds) · 📊 on Health : 37.8% · -2.8% (82 calls)
in progress (365j)
matures : Jun 14, 19
matures : Jun 14, 19
▲ Outperform · 🎯$28
Price at call : $22.49 — upside +24%
Today : $28.83 — upside -3%
Expected +24% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on HSTM : 50% (2 calls matureds) · 📊 on Health : 37.8% · -2.8% (82 calls)
+18.1%
stock +18% · XLV +7%
matured Oct 25, 18
■ Hold neutral · not a buy
🎯 on HSTM : 50% (2 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Oct 25, 18
matures : Oct 25, 18
First Analysis
Jul 26, 17
■ Equal-Weight neutral · not a buy
🎯 on HSTM : 50% (2 calls matureds) · 📊 unranked overall
in progress (365j)
matures : Jul 26, 18
matures : Jul 26, 18
First Analysis
Jan 23, 17
▼ Underweight · 🎯$18
Price at call : $21.45 — upside -16%
Today : $28.83 — upside -38%
Expected -16% · Actual +14% · Reason (≤ −15%) : ✗ No
🎯 on HSTM : 50% (2 calls matureds) · 📊 unranked overall
-13.9%
stock +14% · XLV +27%
matured Jan 23, 18
▲ Outperform
Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on HSTM : 50% (2 calls matureds) · 📊 on Health : 37.8% · -2.8% (82 calls)
-8.4%
stock -8% · XLV +20%
matured Dec 2, 17
Craig-Hallum ↗
Nov 4, 16
■ Hold neutral · not a buy
🎯 on HSTM : no call matured yet · 📊 on Health : 60.9% · +21.4% (23 calls)
in progress (365j)
matures : Nov 4, 17
matures : Nov 4, 17
Canaccord Genuity ↗
Nov 4, 16
■ Hold neutral · not a buy
🎯 on HSTM : 0% (1 call matured) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Nov 4, 17
matures : Nov 4, 17
First Analysis
Jul 27, 16
■ Equal-Weight neutral · not a buy
🎯 on HSTM : 50% (2 calls matureds) · 📊 unranked overall
in progress (365j)
matures : Jul 27, 17
matures : Jul 27, 17
Barrington Research ↗
Jun 29, 16
▲ Outperform · 🎯$30
Price at call : $26.51 — upside +13%
Today : $28.83 — upside +4%
Expected +13% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on HSTM : 0% (1 call matured) · 📊 on Health : 35.1% · -4.0% (57 calls)
-0.1%
stock -0% · XLV +12%
matured Jun 29, 17
FBR Capital
Mar 29, 16
▲ Outperform · 🎯$27
Price at call : $21.86 — upside +24%
Today : $28.83 — upside -6%
Expected +24% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on HSTM : 100% (1 call matured) · 📊 unranked overall
+9.7%
stock +10% · XLV +10%
matured Mar 29, 17
▲ Buy
Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on HSTM : 50% (2 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
+4.1%
stock +4% · XLV +11%
matured Feb 16, 17
Raymond James ↗
Aug 3, 15
■ Market Perform neutral · not a buy
🎯 on HSTM : no call matured yet · 📊 on Health : 39.9% · -2.0% (218 calls)
in progress (365j)
matures : Aug 2, 16
matures : Aug 2, 16
■ Hold neutral · not a buy
🎯 on HSTM : 50% (2 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Jul 21, 16
matures : Jul 21, 16
Canaccord Genuity ↗
Jul 16, 15
▲ Buy · 🎯$37
Price at call : $32.14 — upside +15%
Today : $28.83 — upside +28%
Expected +15% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on HSTM : 0% (1 call matured) · 📊 on Health : 38.9% · -0.9% (144 calls)
-16.5%
stock -16% · XLV -4%
matured Jul 15, 16
▲ Buy
Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on HSTM : 50% (2 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-17.5%
stock -17% · XLV -7%
matured May 19, 16
■ Neutral neutral · not a buy · 🎯$27
Price at call : $24.79 — gap to target +9%
Today : $28.83 — gap to target -6%
🎯 on HSTM : 50% (2 calls matureds) · 📊 on Health : 37.8% · -2.8% (82 calls)
in progress (365j)
matures : Mar 18, 16
matures : Mar 18, 16
Northland Capital Markets ↗
Aug 1, 14
▲ Outperform
Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on HSTM : 50% (2 calls matureds) · 📊 on Health : 15.4% · -20.8% (13 calls)
+12.4%
stock +12% · XLV +26%
matured Aug 1, 15
■ Hold neutral · not a buy
🎯 on HSTM : no call matured yet · 📊 on Health : 44.8% · +6.7% (96 calls)
in progress (365j)
matures : Jun 17, 15
matures : Jun 17, 15
Northland Capital Markets ↗
Apr 2, 14
■ Market Perform neutral · not a buy · 🎯$30
Price at call : $26.49 — gap to target +13%
Today : $28.83 — gap to target +4%
🎯 on HSTM : 50% (2 calls matureds) · 📊 on Health : 15.4% · -20.8% (13 calls)
in progress (365j)
matures : Apr 2, 15
matures : Apr 2, 15
Noble Capital Markets
Apr 1, 14
▲ Buy · 🎯$34
Price at call : $27.1 — upside +25%
Today : $28.83 — upside +18%
Expected +25% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on HSTM : 0% (1 call matured) · 📊 unranked overall
-6.9%
stock -7% · XLV +22%
matured Apr 1, 15
First Analysis
Feb 20, 14
▼ Underweight · 🎯$36
Price at call : $28.76 — upside +25%
Today : $28.83 — upside +25%
Expected +25% · Actual -8% · Reason (≤ −15%) : ✗ No
🎯 on HSTM : 50% (2 calls matureds) · 📊 unranked overall
+8.0%
stock -8% · XLV +23%
matured Feb 20, 15
Northland Capital Markets ↗
Sep 25, 13
▲ Outperform · 🎯$43
Price at call : $37.69 — upside +14%
Today : $28.83 — upside +49%
Expected +14% · Actual -35% · Reason (≥ +15%) : ✗ No
🎯 on HSTM : 50% (2 calls matureds) · 📊 on Health : 15.4% · -20.8% (13 calls)
-35.3%
stock -35% · XLV +27%
matured Sep 25, 14
Avondale Partners
May 28, 13
▲ Market Outperform · 🎯$31
Price at call : $25.53 — upside +21%
Today : $28.83 — upside +8%
Expected +21% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on HSTM : 100% (1 call matured) · 📊 unranked overall
+2.1%
stock +2% · XLV +22%
matured May 28, 14
Frequently asked questions
Should I buy HealthStream, Inc. stock?
This isn't buy advice. For HealthStream, Inc., the analyst consensus is "Hold", with an average price target of $27.00 (-6% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 50% of the time (2 calls tracked on HealthStream, Inc.). We show the numbers — you decide.
Is it too late to buy HealthStream, Inc.? How high can it go?
The most bullish analyst target on HealthStream, Inc. is $27.00 (-6% above today's price); the average is $27.00. That's the upside they see. Check how reliable those analysts have actually been on HealthStream, Inc. on our site before trusting it.
Is HealthStream, Inc. still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 4 analysts have a real record on HealthStream, Inc., the best hitting 50% over 2 calls. Current consensus: "Hold". Make your call on data, not noise.
What has HealthStream, Inc.'s past performance been?
Historical returns and a "how much if I had invested" calculator: HSTM performance & returns.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX